|
|
|
Insider
Information: |
Khattar Jack A. |
Relationship: |
Director |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,378,841 |
|
Indirect Shares
|
2,118,700 |
|
|
Direct
Value |
$23,786,490 |
|
|
Indirect Value
|
$26,573,476 |
|
|
Total
Shares |
3,497,541 |
|
|
Total
Value |
$50,359,965 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-42.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Supernus Pharmaceuticals Inc |
SUPN |
President, CEO, Director |
2024-02-28 |
915,217 |
2024-02-28 |
1,022,450 |
Premium* |
|
Tesaro, Inc. |
TSRO |
President, CEO, Director |
2016-03-29 |
444,124 |
2016-03-29 |
1,096,250 |
Premium* |
|
Scpharmaceuticals Inc. |
SCPH |
Director |
2021-12-03 |
5,000 |
2021-12-03 |
0 |
Premium* |
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SUPN |
Supernus Pharmaceuticals ... |
President, CEOOfficer |
|
2012-04-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,125,000 |
|
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2013-04-04 |
4/A |
D |
$0.00 |
$0 |
I/I |
(11,000) |
1,114,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2014-03-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,000) |
1,107,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2015-03-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,000) |
1,101,000 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President, CEO |
|
2016-03-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,000) |
1,094,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2016-03-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,000) |
1,094,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2017-04-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,250) |
1,089,750 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President & CEO |
|
2018-04-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,800) |
1,085,950 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2019-03-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,500) |
1,081,450 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2020-03-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(13,000) |
1,068,450 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2021-03-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
1,058,450 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-03-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,750) |
1,047,700 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-02-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,750) |
1,038,950 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2024-02-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(16,500) |
1,022,450 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
932,005 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2024-02-28 |
4 |
D |
$27.94 |
$469,057 |
D/D |
(16,788) |
915,217 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
897,005 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
892,463 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-09-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
884,267 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-12-22 |
4 |
D |
$27.66 |
$330,758 |
D/D |
(11,958) |
880,505 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-09-07 |
4 |
D |
$32.10 |
$539,408 |
D/D |
(16,804) |
867,463 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
864,272 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-05-11 |
4 |
D |
$36.47 |
$547,232 |
D/D |
(15,005) |
849,267 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
833,022 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-21 |
4 |
OE |
$9.56 |
$176,592 |
D/D |
18,472 |
826,053 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|